Merge collaborates with Methodist Healthcare

Article

Methodist Healthcare of Memphis has joined the Merge Premier Partner Program. Through this program, Merge collaborates with leading clinical partners to develop medical communication and informatics solutions for diagnostic imaging that lower healthcare

Methodist Healthcare of Memphis has joined the Merge Premier Partner Program. Through this program, Merge collaborates with leading clinical partners to develop medical communication and informatics solutions for diagnostic imaging that lower healthcare operating costs, increase efficiencies, reduce medical errors, and improve patient care. As a partner, Methodist Healthcare will receive a license to Merge’s medical software tools, such as MergeWeb for clinical workflow research and product development. Merge will receive ongoing clinical input, commercial rights for products codeveloped with its partners, and a network of clinical trial and reference sites. Several of Merge’s Premier Partners are its customers. Other partners include Medical College of Wisconsin, UCLA Medical Center, and Mallinckrodt Institute of Radiology.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.